0001209191-23-037340.txt : 20230615 0001209191-23-037340.hdr.sgml : 20230615 20230615162333 ACCESSION NUMBER: 0001209191-23-037340 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230614 FILED AS OF DATE: 20230615 DATE AS OF CHANGE: 20230615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERRY GREGORY D CENTRAL INDEX KEY: 0001236371 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37773 FILM NUMBER: 231017676 MAIL ADDRESS: STREET 1: C/O IMMUNOGEN, INC. STREET 2: 830 WINTER ST. CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merus N.V. CENTRAL INDEX KEY: 0001651311 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM BUSINESS PHONE: 31 030 253 8800 MAIL ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM FORMER COMPANY: FORMER CONFORMED NAME: Merus B.V. DATE OF NAME CHANGE: 20150819 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-14 0 0001651311 Merus N.V. MRUS 0001236371 PERRY GREGORY D C/O MERUS N.V. UPPSALALAAN 17 UTRECHT P7 3584 CT NETHERLANDS 0 1 0 0 Chief Financial Officer 0 Share option (right to buy 26.50 2023-06-14 4 A 0 372924 0.00 A 2033-06-14 Common Shares 372924 372924 D The options vest and become exercisable as to 25% of the underlying shares on the first anniversary of the date of grant, with the remaining underlying shares vesting in 36 substantially equal monthly installments thereafter, such that the options shall be vested and exercisable as to all shares on the fourth anniversary of the date of grant, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date. /s/ Peter Silverman as attorney-in-fact 2023-06-15